Dr. Martha Boeckenfeld Shares VetiGel Creation Experiment: How A 17-Year-Old Mixed Algae in a Small Hidden Lab
Dr. Martha Boeckenfeld, CEO and Founder of the Marthaverse, posted on LinkedIn:
“A 17-year-old mixed algae in a small lab hidden on his grandfather’s Hudson Valley vineyard.

It grabbed wet tissue and wouldn’t let go.
That experiment turned into VetiGel: a plant-based gel that seals wounds and helps blood clot.
Trauma care’s hard problem:
Severe bleeding is the leading cause of preventable trauma death.
A major arterial bleed can kill in 3–5 minutes.
Most products need firm pressure, the right wound shape, and time.
Deep, jagged wounds are tough to pack.
What Joe built:
- A gel that seals fast and triggers clotting
- No manual pressure
- Stops bleeding in under 20 seconds
Works on skin and organs
The proof: In veterinary surgery on 16 dogs, VetiGel cut blood loss from 78 mL to 6.7 mL. Time to hemostasis dropped from 25 minutes to under 2.
Cresilon later created TraumaGel for humans. It’s FDA cleared.
It made Time’s “Best Inventions of 2025.”
The Department of Defense signed on.
Picture an earthquake. A mother pinned under rubble, bleeding from a deep wound. No ambulance for 40 minutes. A responder applies gel. The bleeding stops.
She’s still alive when rescue arrives.
We spent decades accepting some bleeds are too fast and too deep to stop in time. A kid in a vineyard lab didn’t accept that.
Follow me, Dr. Martha Boeckenfeld, for stories where curiosity changes medicine.
Share if you think big medical advances can start everywhere. We just need imagination!
This is my find for YOU on the the last Day of 2025 to show, how human imagination is saving lives!”
Explore more posts for deeper insights into hemostasis with Hemostasis Today.
-
Nov 14, 2026, 00:23Saji Kumar: The Role of Agentic AI in Blood Bank Inventory Coordination
-
Nov 14, 2026, 00:04Carlos A. Metidieri Menegozzo: The First Priority in Trauma Transfusion May Be Time to First Blood Product
-
Nov 13, 2026, 23:43Alamgir Hosen Ronit: Corrected Platelet Count in EDTA Induced Platelet Aggregation
-
Nov 13, 2026, 23:32Evi Loos: Can PRP Improve Pain in Thumb Base Osteoarthritis?
-
Nov 13, 2026, 23:10Cesar de Almeida Neto: Digital Connectivity Can Transform Plateletpheresis Practice
-
Nov 13, 2026, 23:10Chien-Wen Liew: Where PRP Actually Sits in the Evidence
-
Nov 13, 2026, 23:08Erika Koppers: Continuing the Collaborative Journey Towards Equitable Haemophilia Care in South Africa
-
Nov 13, 2026, 23:06Büşra Ece Günaydın: A New Approach to Factor VIII Gene Insertion for Hemophilia A
-
Nov 13, 2026, 22:57Rolf Bekendam: Moderating a Conversation With Experts on Rare Bleeding Disorders